Patexia Research

Case number 3:18-cv-11220

Lawsuits

AMGEN INC. v. ANNORA PHARMA PRIVATE LIMITED et al > Summary

Court Case Number 3:18-cv-11220

Filing Date Jun 28, 2018

Termination Date Apr 6, 2020

Court New Jersey District Court

Status Dismissed - Settled

JudgesMichael A. Shipp, Douglas E. Arpert

Plaintiff

2

Defendant

2

Annora Pharma Private Limited

Plaintiff Attorneys

13

Amgen
Attorney Name: Charles H. Chevalier
Gibbons P.C.

Amgen
Attorney Name: Christine A. Gaddis
Gibbons P.C.

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Celgene
Attorney Name: George F. Pappas
Covington & Burling LLP

Celgene
Attorney Name: Christopher N. Sipes
Covington & Burling LLP

Celgene
Attorney Name: Michael N. Kennedy
Covington & Burling LLP

Celgene
Attorney Name: Alexa R. Hansen
Covington & Burling LLP

Amgen
Attorney Name: Eric M. Agovino
Amgen

Amgen
Attorney Name: Christina N. Gifford
Amgen

Amgen
Attorney Name: Wendy A. Whiteford
Amgen

Attorney Name: Sarah A. Geers

Attorney Name: Christina N. Gifford

Attorney Name: Charles M. Lizza

Defendant Attorneys

11

Annora Pharma Private Limited
Attorney Name: Stephen M. Klein
Sills Cummis & Gross

Annora Pharma Private Limited
Attorney Name: Bisma Muhammed
Sills Cummis & Gross

Annora Pharma Private Limited
Attorney Name: Mark S. Olinsky
Sills Cummis & Gross

Hetero
Attorney Name: Stephen M. Klein
Sills Cummis & Gross

Hetero
Attorney Name: Bisma Muhammed
Sills Cummis & Gross

Hetero
Attorney Name: Mark S. Olinsky
Sills Cummis & Gross

Annora Pharma Private Limited
Attorney Name: Bruce Jefferson Boggs Jr.
Merchant & Gould

Annora Pharma Private Limited
Attorney Name: Christopher J. Sorenson
Merchant & Gould

Hetero
Attorney Name: Bruce Jefferson Boggs Jr.
Merchant & Gould

Hetero
Attorney Name: Christopher J. Sorenson
Merchant & Gould

Attorney Name: Bruce Jefferson Boggs Jr.

Counter Defendant

4

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Counter Claimant

4

Hetero
Attorney Name: Mark S. Olinsky
Sills Cummis & Gross

Annora Pharma Private Limited
Attorney Name: Mark S. Olinsky
Sills Cummis & Gross

Hetero
Attorney Name: Stephen M. Klein
Sills Cummis & Gross

Annora Pharma Private Limited
Attorney Name: Stephen M. Klein
Sills Cummis & Gross

Cause

15:1126 Patent Infringement

Related Patents

Doc No	Title	Issue date
10092541	Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast	Oct 9, 2018
09872854	Methods for the treatment of psoriatic arthritis using apremilast	Jan 23, 2018
09724330	Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione	Aug 8, 2017
09018243	Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof	Apr 28, 2015
08802717	Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione	Aug 12, 2014
08455536	Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione	Jun 4, 2013
07893101	Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof	Feb 22, 2011
07659302	Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione	Feb 9, 2010
07427638	(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof	Sep 23, 2008
07208516	Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione	Apr 24, 2007
06962940	(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof	Nov 8, 2005